Jump Financial’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Jump Financial’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,693	Closed	-$31K	–	2023
2021 Q4	$31K	Sell	10,693 -2,913	-21%	-$10.8K	﹤0.01%	1328
2021 Q3	$58K	Buy	13,606 +689	+5%	+$3.07K	﹤0.01%	1024
2021 Q2	$68K	Buy	+12,917	New	+$62.1K	0.01%	1016
2020 Q4	–	Sell	-12,500	Closed	-$41K	–	1239
2020 Q3	$41K	Buy	+12,500	New	+$45.9K	0.01%	727

Other funds holding ZYNE

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jump Financial's ZYNE Position: Q1 2022 in Review

Jump Financial sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q1 2022, closing a stake of 10,693 shares — an estimated $31K sold.

Jump Financial first reported a position in ZYNE in Q3 2020 and held it in 4 quarters. The position peaked at $68K in Q2 2021. 59 funds tracked by Wall St. Rank hold ZYNE as of Q1 2022.

Jump Financial reported no remaining Zynerba Pharmaceuticals, Inc position as of Q1 2022 after selling out during the quarter.
Jump Financial sold 10,693 Zynerba Pharmaceuticals, Inc shares in Q1 2022, an estimated $31K.
Jump Financial first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2020 and held it in 4 quarters.
Jump Financial's Zynerba Pharmaceuticals, Inc position peaked at $68K in Q2 2021.
59 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q1 2022.

Based on Jump Financial's 13F filing for Q1 2022, filed 12 May 2022.